Intervention | No. (%) of patients* n = 106 |
---|---|
Respiratory management | |
Invasive mechanical ventilation | 65 (61.3) |
High PEEP† | 22 (33.9) |
PEEP at 24 h postintubation, median (IQR), cm H2O, n = 63 | 10 (8–12) |
Prone positioning | 29 (27.4) |
Intubated | 19 (65.5) |
Not intubated | 10 (34.5) |
HFNC | 51 (48.1) |
Initial respiratory support‡ | 29 (56.9) |
Postextubation support | 24 (47.1) |
Medication | |
Neuromuscular blockade | 24 (22.6) |
Corticosteroids | 53 (50.0) |
Symptom onset to receipt of corticosteroids, d, median (IQR) | 13 (10–17) |
Azithromycin | 94 (88.7) |
Hydroxychloroquine | 75 (70.8) |
Tocilizumab | 11 (10.4) |
Oseltamivir | 8 (7.5) |
Lopinavir–ritonavir | 6 (5.7) |